(Q44127867)

30 November 2017

title

Treatment of latent tuberculosis infection: update of guidelines, 2006 (English)

1 reference

30 November 2017

1 reference

1 reference

Raquel Duarte

1

1 reference

30 November 2017

Joana Amado

2

1 reference

30 November 2017

Helena Lucas

3

1 reference

30 November 2017

José Manuel Sapage

4

1 reference

30 November 2017

Portuguese Society of Pulmonology

5

1 reference

30 November 2017

publication date

1 May 2007

1 reference

Revista portuguesa de pneumologia

30 November 2017

published in

1 reference

30 November 2017

volume

13

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

397-418

1 reference

The global tuberculosis situation and the new control strategy of the World Health Organization

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

Tuberculosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

Clinical practice. Latent tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Joint Tuberculosis Committee of the British Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

Diagnosing latent tuberculosis infection: the 100-year upgrade

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

Disseminated BCG in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

Short-course rifamycin and pyrazinamide treatment for latent tuberculosis infection in patients with HIV infection: the 2-year experience of a comprehensive community-based program in Broward County, Florida

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930359-7

7 January 2021

10.1016/S0873-2159(15)30359-7

Identifiers

DOI

1 reference

30 November 2017

1 reference